ESSA Pharma

$27.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.66 (+6.53%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ESSA Pharma and other stocks, options, and ETFs commission-free!

About EPIX

ESSA Pharma, Inc. engages in the development of small molecule drugs for prostate cancer. It focuses on producing drugs which selectively block the amino-terminal domain (NTD) of the androgen receptor (AR), potentially overcoming the known AR-dependent resistance mechanisms of castration-resistant prostate cancer (CRPC), and providing CRPC patients with the potential for increased progression-free and overall survival. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada. The listed name for EPIX is ESSA Pharma Inc. Common Stock.

CEO

David R. Parkinson

Employees

Headquarters

Vancouver, British Columbia

Founded

2009

Market Cap

921.22M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

698.07K

High Today

$27.09

Low Today

$24.83

Open Price

$26.40

Volume

202.19K

52 Week High

$32.69

52 Week Low

$3.00

EPIX Earnings

-$0.52

-$0.35

-$0.17

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Estimated

— per share

Actual

Expected May 6, Pre-Market